期刊文献+

MiR200对肾癌细胞增殖的影响分析

Analysis of the Effect of MiR200 on the Proliferation of Renal cell Carcinoma Cells
下载PDF
导出
摘要 目的研究MiR200对肾癌细胞增殖的影响。方法整群选取2013年1月—2015年1月于齐齐哈尔医学院第三附属医院就诊的51例肾癌患者病理细胞和正常癌旁组织细胞,以及构建裸鼠肾癌模型,测量MiR-200在不同细胞中的表达量和肿瘤增殖情况。结果 MiR-200在裸鼠的SN12-PM6和人的786-o、A498表达中均低于正常组织的表达(P〈0.05),在48 h后能够抑制肾癌细胞增殖(P〈0.05),48~72 h抑制情况最为显著(P〈0.05)。结论 MiR-200在肿瘤细胞中呈低表达水平,能够抑制肾癌细胞增殖并能够抑制裸鼠肾癌细胞生长。 Objective MiR200 proliferation of kidney cancer. Methods Group selection from January 2013- January 2015,51 patients in the Third Affiliated Hospital of Qiqihar Medical University with renal cell carcinoma pathological cells and adjacent normal tissue cells, renal cancer and build nude model, measuring MiR-200 in different cells and the expression of tumor proliferation. Results MiR-200 in nude mice SN12-PM6 and human 786-o, A498 expression were lower than normal tissue expression(P〈0.05), at 48 h after kidney can inhibit cancer cell proliferation(P〈0.05), 48~72 h inhibition was most significant,(P〈0.05). Conclusion MiR-200 showed low levels of expression in tumor cells, can inhibit the proliferation of renal cell carcinoma and renal cancer cell growth in nude mice can be suppressed.
出处 《中外医疗》 2016年第17期23-24,共2页 China & Foreign Medical Treatment
基金 齐齐哈尔市科学技术计划项目任务(FSGG201422)
关键词 MiR200 肾癌细胞 增殖 MiR200 Renal cell carcinoma proliferation
  • 相关文献

参考文献7

  • 1赵亚伟,王砺,李前跃,马旺,王勤章,欧阳松.121例肾细胞癌患者临床及预后分析[J].山东医药,2013,53(42):55-56. 被引量:2
  • 2丰水强.局限性肾细胞癌肾切除后5年复发的临床特征和预后[J].现代泌尿生殖肿瘤杂志,2011,3(4):233-233. 被引量:2
  • 3Tao Y,Guo Y,Liu W,et al.AKT inhibitor suppresses hyperthermia-induced Ndrg2 phosphorylation in gastric cancer cells[J].Braz J Med Biol Res,2013,46(4):394-404.
  • 4Schena,F.P,Serino,G.,Sallustio,F.Micro RNAs in kidney diseases:New promising biomarkers for diagnosis and monitoring[J].2014,29(4):154-163.
  • 5Mirzoeva,O.K,Collisson,E.A,Schaefer,P.M,et al.Subtypespecific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma[J].Molecular cancer therapeutics,2013,12(10):1124-1131.
  • 6Abdel A M,Wassef M A,Ahmed H H,et al.The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy[J].Diabetol Metab Syndr,2014,6(1):34.
  • 7Yan Xl,Li Y,Xiao LX,et al.Regulation of colorectal carcinoma stemness,growth and metastasis by a mi R-200c-Sox2negative feedback loop mechanism[J].Clinical Cancer Research.2014,20(10):2631-2642.

二级参考文献9

  • 1那彦群,叶章群,孙颖浩,等.肿瘤学临床实践指南[M].2010:12.
  • 2Volpe A, Patard JJ. Prognostic factors in renal cell carcinoma[ J]. World J Urol, 2010, 28(3) : 3193-27.
  • 3Giannakis D, Tsili AC, Zioga A, et al. Early-stage sarcomatoid re- nal cell carcinoma : mu|tidetector CT findings [ J ]. Urol Int, 2009, 82 (3) :367-369.
  • 4Nazim SM, Ather MH, Hafeez K, et al. Accuracy of muhidetector CT scans in staging of renal carcinoma[ J. Int J Surg, 2011,9 ( 1 ) :86-90.
  • 5Schlomer B, Figenshau RS, "fan /, et aL Pathological features of renal neoplasms classified by size and symptomatology[ J ]. Urol, 2006,176(4 Pt 1 ) :1317-1320.
  • 6Tsui KH, Shvarts O, Smith RB. et al. Renal cell carcinoma: Prog- nostuc significance of incidentally detected tumors [ J ]. J Urol, 2000,163(2) :426-430.
  • 7Jayson M, Sanders H. Increased incidence of serendipitously dis- covered renal cell carcinoma [ J ]. J Urology, 1998,51 ( 2 ) : 203- 205.
  • 8Jean-Jacques P, Emnmnuelle L,Luca C, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma [J]. J Urol, 2004,172(3) :858-862.
  • 9赵亚伟,王勤章,丁国富,李强,李应龙,倪钊,王新敏,王江平,钱彪,王文晓.肾细胞癌预后相关因素分析[J].山东医药,2013,53(12):30-31. 被引量:6

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部